img

Global Immune Supplements Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Immune Supplements Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Immune Supplements Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Immune Supplements industry at home and abroad, estimate the overall market scale of the Immune Supplements industry and the market share of major countries, Immune Supplements industry, and study and judge the downstream market demand of Immune Supplements through systematic research, Analyze the competition pattern of Immune Supplements, so as to help solve the pain points of various stakeholders in Immune Supplements industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Immune Supplements Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Immune Supplements Market?
Qivaro
BYHWALTH
APOLLO
Swisse
Amway
GNC
ORTHOMOL
Blackmores
Conba
Abbott
Puritan
Major Type of Immune Supplements Covered in XYZResearch report
Liquid
Capsule
Powder
Others
Application Segments Covered in XYZResearch Market
Children
Aldult

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Immune Supplements Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Immune Supplements Market by Value
2.2.1 Global Immune Supplements Revenue by Type
2.2.2 Global Immune Supplements Market by Value (%)
2.3 Global Immune Supplements Market by Production
2.3.1 Global Immune Supplements Production by Type
2.3.2 Global Immune Supplements Market by Production (%)

3. The Major Driver of Immune Supplements Industry
3.1 Historical & Forecast Global Immune Supplements Demand
3.2 Largest Application for Immune Supplements (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Immune Supplements Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Immune Supplements Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Immune Supplements Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Immune Supplements Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Immune Supplements Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Immune Supplements Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Immune Supplements Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Immune Supplements Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Immune Supplements Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Immune Supplements Average Price Trend
12.1 Market Price for Each Type of Immune Supplements in US (2018-2022)
12.2 Market Price for Each Type of Immune Supplements in Europe (2018-2022)
12.3 Market Price for Each Type of Immune Supplements in China (2018-2022)
12.4 Market Price for Each Type of Immune Supplements in Japan (2018-2022)
12.5 Market Price for Each Type of Immune Supplements in India (2018-2022)
12.6 Market Price for Each Type of Immune Supplements in Korea (2018-2022)
12.7 Market Price for Each Type of Immune Supplements in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Immune Supplements Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Immune Supplements

14. Immune Supplements Competitive Landscape
14.1 Qivaro
14.1.1 Qivaro Company Profiles
14.1.2 Qivaro Product Introduction
14.1.3 Qivaro Immune Supplements Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 BYHWALTH
14.2.1 BYHWALTH Company Profiles
14.2.2 BYHWALTH Product Introduction
14.2.3 BYHWALTH Immune Supplements Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 APOLLO
14.3.1 APOLLO Company Profiles
14.3.2 APOLLO Product Introduction
14.3.3 APOLLO Immune Supplements Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Swisse
14.4.1 Swisse Company Profiles
14.4.2 Swisse Product Introduction
14.4.3 Swisse Immune Supplements Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Amway
14.5.1 Amway Company Profiles
14.5.2 Amway Product Introduction
14.5.3 Amway Immune Supplements Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 GNC
14.6.1 GNC Company Profiles
14.6.2 GNC Product Introduction
14.6.3 GNC Immune Supplements Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 ORTHOMOL
14.7.1 ORTHOMOL Company Profiles
14.7.2 ORTHOMOL Product Introduction
14.7.3 ORTHOMOL Immune Supplements Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Blackmores
14.8.1 Blackmores Company Profiles
14.8.2 Blackmores Product Introduction
14.8.3 Blackmores Immune Supplements Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Conba
14.9.1 Conba Company Profiles
14.9.2 Conba Product Introduction
14.9.3 Conba Immune Supplements Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Abbott
14.10.1 Abbott Company Profiles
14.10.2 Abbott Product Introduction
14.10.3 Abbott Immune Supplements Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Puritan
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Immune Supplements Industry (Volume)
Figure 2. Immune Supplements Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Immune Supplements Revenue in 2022
Figure 5. US Immune Supplements Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Immune Supplements Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Immune Supplements Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Immune Supplements Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Immune Supplements Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Immune Supplements Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Immune Supplements Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Immune Supplements Revenue, by Type (Million USD) (2018-2028)
Table 4. Immune Supplements Production, by Type (K Unit) (2018-2028)
Table 5. Immune Supplements Demand (K Unit) by Application (2018-2028)
Table 6. Immune Supplements Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Immune Supplements Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Immune Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Immune Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Immune Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Immune Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Immune Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Immune Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Immune Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Immune Supplements in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Immune Supplements in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Immune Supplements in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Immune Supplements in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Immune Supplements in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Immune Supplements in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Immune Supplements in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Qivaro Profiles
Table 61. Qivaro Immune Supplements Product Introduction
Table 62. Qivaro Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Qivaro Strategic initiatives
Table 64. BYHWALTH Profiles
Table 65. BYHWALTH Immune Supplements Product Introduction
Table 66. BYHWALTH Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. BYHWALTH Strategic initiatives
Table 68. APOLLO Profiles
Table 69. APOLLO Immune Supplements Product Introduction
Table 70. APOLLO Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. APOLLO Strategic initiatives
Table 72. Swisse Profiles
Table 73. Swisse Immune Supplements Product Introduction
Table 74. Swisse Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Swisse Strategic initiatives
Table 76. Amway Profiles
Table 77. Amway Immune Supplements Product Introduction
Table 78. Amway Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Amway Strategic initiatives
Table 80. GNC Profiles
Table 81. GNC Immune Supplements Product Introduction
Table 82. GNC Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. GNC Strategic initiatives
Table 84. ORTHOMOL Profiles
Table 85. ORTHOMOL Immune Supplements Product Introduction
Table 86. ORTHOMOL Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. ORTHOMOL Strategic initiatives
Table 88. Blackmores Profiles
Table 89. Blackmores Immune Supplements Product Introduction
Table 90. Blackmores Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Blackmores Strategic initiatives
Table 92. Conba Profiles
Table 93. Conba Immune Supplements Product Introduction
Table 94. Conba Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Conba Strategic initiatives
Table 97. Abbott Profiles
Table 98. Abbott Immune Supplements Product Introduction
Table 99. Abbott Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Abbott Strategic initiatives
Table 101. Puritan Profiles
Table 102. Puritan Immune Supplements Product Introduction
Table 103. Puritan Immune Supplements Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Puritan Strategic initiatives